Gerresheimer

Activities: Drug Delivery

Gerresheimer is the global partner for pharmaceutics, biotech, healthcare, and cosmetics with a very broad product range for pharmaceutical and cosmetic containment solutions and drug delivery systems.

Visit website

Profile

Gerresheimer is the innovative system and solution provider and global partner for the pharma and biotech industry. The company offers a comprehensive portfolio of pharmaceutical containment solutions, drug delivery systems and medical devices as well as solutions for the health and cosmetics industry.

The product range includes digital solutions for therapy support, medication pumps, syringes, pens, auto-injectors and inhalers as well as vials, ampoules, tablet containers, dropper bottles, other bottles and more. Gerresheimer ensures the safe delivery and administration of drugs to the patient. With 36 production sites in 16 countries in Europe, America and Asia, Gerresheimer has a global presence and produces locally for the regional markets.

With over 11,000 employees, the company generated revenues of around €1.82bn in 2022. Gerresheimer AG is listed in the MDAX on the Frankfurt Stock Exchange (ISIN: DE000A0LD6E6). www.gerresheimer.com

Social media

 

Gerresheimer Gerresheimer Gerresheimer

 

 

 

Trending Articles

  1. Catalent Boston adds to oral spray drying capacity to support late-stage clinical trials and commercialisation Catalent, the leading provider of oral drug development solutions, bioavailability enhancing technologies and flexible manufacturing, has completed a series of upgrades to its...
  2. £20m Scottish oligonucleotide manufacturing innovation centre now under construction The centre will act as an innovation centre, assisting in the development and optimisation of oligonucleotide manufacturing processes, while also bolstering the UK's...
  3. Novo Nordisk invests DKK 8.5bn into new Danish modular production site This is the first time this century that Novo Nordisk has invested into its Danish production capabilities, with the site being capable of manufacturing product types within...
  4. Scinai Immunotherapeutics establishes Delaware-based US CDMO subsidiary The biopharmaceutical company now operates contract development and manufacturing services in both Jerusalem and Delaware
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Merck jumps on the GLP-1 therapeutic bandwagon by licensing Hansoh Pharma's HS-10535 Merck will be responsible for the development, manufacture and commercialisation of the investigational preclinical oral GLP-1 receptor agonist

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Packaging

Gerresheimer acquires Bormioli Pharma Group through Blitz LuxCo Sarl merger

Gerresheimer and Bormioli Pharma will merge to provide the biotech and pharmaceutical industries with primary packaging solutions, dosing systems, closure solutions and accessories
Manufacturing

Gerresheimer begins €100m expansion of its pharmaceutical syringe production capabilities

The extension of its Skopje, North Macedonia site will allow Gerresheimer to better serve the pharmaceutical and biotech industries
Drug Delivery

Gerresheimer's Gx Inbeneo wins Red Dot award

The company's autoinjector allows patients to effectively self-administer biologics in the comfort of their own home
Marketing

Gerresheimer at CPHI 2024: innovative solutions and expert presentations

Gerresheimer, an innovative systems and solutions provider and global partner to the pharma, biotech and cosmetics industries, will be presenting its comprehensive portfolio of containment solutions, drug delivery systems and digital solutions at this year's CPHI
Manufacturing

SCHOTT, Gerresheimer and Stevanato Group form the 'Alliance for RTU'

The scheme will promote the adoption of ready-to-use (RTU) vials and cartridges for CDMOs in the injectable scene
Sustainability

Gerresheimer further enhances sustainability credentials and achieves EcoVadis Gold certification

The company ranked amongst the top 3% of companies rated by EcoVadis for its sustainability strategy
Drug Delivery

Meet the experts, watch the presentation, join the after show party at booth 20B1!

Visit our booth, browse our comprehensive product range or talk to our experts. Get insights on how we could support you with our best-in-class containment solutions and innovative drug delivery devices at CPHI in Milan
Subscribe now